Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2004;44:72-77
Published online before print May 17, 2004, doi: 10.1161/01.HYP.0000130483.83154.37
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
44/1/72    most recent
01.HYP.0000130483.83154.37v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leik, C. E.
Right arrow Articles by Walsh, S. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leik, C. E.
Right arrow Articles by Walsh, S. W.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*High Risk Pregnancy
Related Collections
Right arrow Other hypertension
Right arrow Other Vascular biology

(Hypertension. 2004;44:72.)
© 2004 American Heart Association, Inc.


Scientific Contributions

Neutrophils Infiltrate Resistance-Sized Vessels of Subcutaneous Fat in Women With Preeclampsia

Courtney E. Leik; Scott W. Walsh

From the Departments of Obstetrics and Gynecology and Physiology, Virginia Commonwealth University Medical Center, Richmond.

Correspondence to Dr. Scott W. Walsh, Department of Obstetrics and Gynecology, PO Box 980034, Virginia Commonwealth University Medical Center, Richmond, VA 23298-0034. E-mail swwalsh{at}vcu.edu


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
We examined if there is systemic vascular inflammation and neutrophil infiltration in women with preeclampsia. Resistance-sized vessels (10 to 200 µm) of subcutaneous fat were evaluated from normal nonpregnant women, normal pregnant women, and preeclamptic women. Immunohistochemical staining was performed for: (1) interleukin-8 (IL-8), a potent neutrophil chemokine; (2) intercellular adhesion molecule-1 (ICAM-1; CD54), an endothelial cell adhesion molecule; and (3) CD66b, a neutrophil antigen. Vessels of preeclamptic patients had intense IL-8 staining in the endothelium and vascular smooth muscle, as compared with little or no staining for normal pregnant and normal nonpregnant patients. ICAM-1 was expressed on the endothelium of all patient groups. In preeclamptic patients, ICAM-1 was also expressed on vascular smooth muscle. Vessels of preeclamptic patients had significantly more CD66b staining of neutrophils than did normal pregnant or normal nonpregnant patients. There were significantly more vessels stained, more vessels with neutrophils flattened and adhered to endothelium, more vessels with neutrophils infiltrated into the intima, and more neutrophils per vessel. In conclusion, in women with preeclampsia, there was significant infiltration of neutrophils into maternal systemic vasculature associated with inflammation of the vascular smooth muscle indicated by increased expression of IL-8 and ICAM-1. Neutrophil infiltration provides a reasonable explanation for endothelial and vascular smooth muscle dysfunction in preeclampsia because neutrophils produce toxic substances, which may explain clinical symptoms.


Key Words: neutrophils • preeclampsia • interleukins • cell adhesion molecules • endothelium • adipose tissue


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Neutrophils mediate innate immunity to protect an individual from infection by generation of reactive oxygen species (ROS) and release of granules containing proteolytic enzymes.1 These toxic products kill bacteria, but they can also damage host tissue. There is accumulating evidence of neutrophil involvement in inflammatory diseases not associated with infection.2

Preeclampsia is a hypertensive disorder of human pregnancy and a leading cause of maternal and fetal morbidity and mortality.3 Clinically, it is diagnosed as maternal hypertension with proteinuria. Pathological edema is usually present. The pathophysiology of preeclampsia is associated with neutrophil activation,4 oxidative stress,5,6 and endothelial cell dysfunction.7 Greer et al first reported that neutrophils were activated by measuring a significant increase in neutrophil elastase in the maternal circulation.8 Subsequently, Tsukimori et al and others reported a significant increase in superoxide production by neutrophils obtained from preeclamptic women.9–11 Barden et al reported upregulation of neutrophil ß-integrins.12 Neutrophil activation likely occurs as they circulate through the intervillous space and are exposed to oxidized lipids secreted by the placenta.5,13,14 Although neutrophils are activated, their role in the pathogenesis of preeclampsia is not known. One role could be to act as cellular carriers of oxidative stress from the placenta to the maternal circulation by adhering and infiltrating maternal systemic vasculature.

Neutrophil infiltration into vascular tissue requires vascular expression of a chemotactic agent to attract neutrophils, endothelial expression of adhesion molecules to bind neutrophils to the endothelium, as well as neutrophil activation. To study if neutrophils adhere to endothelium and infiltrate systemic resistance-sized vessels in women with preeclampsia, we used immunohistochemistry to evaluate: (1) vascular smooth muscle expression of interleukin-8 (IL-8), a potent neutrophil chemotactic agent and activator of neutrophils; (2) endothelial expression of intercellular adhesion molecule-1 (ICAM-1), an adhesion molecule that binds ß-integrins on the neutrophil surface, causing them to adhere and flatten onto the endothelium before infiltration; and (3) neutrophil activation and infiltration into systemic vascular tissue. We evaluated neutrophils in preference of other leukocytes because: (1) they are the most abundant of the leukocytes; (2) their numbers increase in pregnancy;3 (3) their numbers further increase in preeclampsia;15 and (4) they produce toxic substances (thromboxane, ROS, myeloperoxidase, and tumor necrosis factor-{alpha}),1,16 which could be responsible for vasoconstriction and vascular cell dysfunction. We hypothesized that in women with preeclampsia, there would be increased expression of vascular smooth muscle IL-8 and endothelial ICAM-1 coincident with infiltration of neutrophils into maternal systemic vascular tissue.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Subcutaneous fat biopsy samples were collected from patients at MCV Hospitals of Virginia Commonwealth University Medical Center. Fat biopsy samples were collected at the time of cesarean section from normal pregnant patients (n=6) and patients with preeclampsia (n=5), or at the time of abdominal or minimally invasive surgery from normal nonpregnant patients (n=4). Preeclampsia was defined according to criteria of the American College of Obstetricians and Gynecologists. Women in active labor were excluded from the study. All patients were nonsmokers. Informed consent was obtained before surgery. This study was approved by the Virginia Commonwealth University Office of Research Subjects Protection. Procedures were in accordance with institutional guidelines.

Subcutaneous fat biopsy samples were used because subcutaneous fat is a highly vascularized tissue representative of the systemic vasculature and it is easily obtained at the time of surgery. Vessels of subcutaneous fat were stained for IL-8, ICAM-1, and CD66b, a granulocyte-specific antigen. CD66b is upregulated and secreted on granulocyte activation. CD66b staining primarily represents neutrophils because they comprise 96% of the granulocyte population.

Details on patients, fat collection, immunohistochemistry, data analysis, and statistical analysis are available in an online supplement at http://www.hypertensionaha.org.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Clinical data for normal nonpregnant, normal pregnant, and patients with preeclampsia are summarized in the Table.


View this table:
[in this window]
[in a new window]
 
Clinical Data for Patient Groups

Results for IL-8, ICAM-1, and CD66b are shown in Figure 1. Staining scores and OD measurements for IL-8 and CD66b were significantly greater for patients with preeclampsia than for normal pregnant or normal nonpregnant patients. There was little or no staining for IL-8 or CD66b in vessels of normal nonpregnant or normal pregnant patients. In contrast, ICAM-1 was expressed in vessels of all groups, with normal pregnant scores and OD significantly lower than preeclamptic or normal nonpregnant scores.



View larger version (14K):
[in this window]
[in a new window]
 
Figure 1. Staining intensity of resistance-sized vessels in subcutaneous fat for IL-8, ICAM-1, and CD66b. Staining intensity for IL-8 and CD66b was markedly greater for patients with preeclampsia (PE) than for normal nonpregnant (NNP) or normal pregnant (NP) patients. Staining intensity for ICAM-1 was significantly lower for NP patients than for PE or NNP patients. Numbers in parentheses represent OD measurements (background OD {approx}50). ODs were highly correlated with staining scores (IL-8, r=0.92; ICAM-1, r=0.56; CD66b, r=0.84). Data are expressed as mean±SE of total vessels scored for each patient group. ***P<0.001.

Staining results for IL-8 are shown in Figure 2. Normal nonpregnant patients had little or no vascular staining (Figure 2a), whereas normal pregnant patients had light staining, including light staining in vascular smooth muscle (Figure 2b). Serial sections of a patient with preeclampsia are shown in Figure 2c to 2f, with staining for IgG as negative control, factor VIII to identify endothelial cells, IL-8, and {alpha}-smooth muscle actin to identify vascular smooth muscle cells. In contrast to normal nonpregnant and normal pregnant patients, patients with preeclampsia had intense IL-8 staining in endothelium, as well as intense IL-8 staining in vascular smooth muscle. Figure 2g shows another example of intense IL-8 staining in vascular smooth muscle verified by staining for {alpha}-smooth muscle actin in a serial section (Figure 2h).



View larger version (115K):
[in this window]
[in a new window]
 
Figure 2. Representative sections of vessels in subcutaneous fat immunostained for IL-8. a, Normal nonpregnant. b, Normal pregnant. c to f, Sequential sections of a PE patient (c, IgG negative control; d, factor VIII; e, IL-8; f, {alpha}-smooth muscle actin). g and h, Sequential sections of a PE patient (g, IL-8; h, {alpha}-smooth muscle actin). Vessels of normal nonpregnant showed little or no staining for IL-8, whereas vessels of normal pregnant showed light brown vascular staining. Vessels of PE showed intense brown staining for IL-8. IL-8 staining was evident in the vascular smooth muscle of PE vessels. A indicates adipocyte; VL, vessel lumen; VSM, vascular smooth muscle. All images are 400x magnification. Scale bars indicate 50 µm.

Staining results for ICAM-1 are shown in Figure 3. In normal nonpregnant women, ICAM-1 was primarily localized to endothelial cells (Figure 3a). In normal pregnant women, ICAM-1 was primarily on the endothelium, with some on the vascular smooth muscle (Figure 3b). In women with preeclampsia, ICAM-1 was present not only on the endothelium but also on the vascular smooth muscle. Serial sections of a patient with preeclampsia are shown in Figure 3c to 3f with staining for IgG as negative control (Figure 3c), factor VIII (Figure 3d), ICAM-1 (Figure 3e), and {alpha}-smooth muscle actin (Figure 3f) demonstrating intense diffuse staining of ICAM-1 in the vascular smooth muscle. Figure 3g shows another example of ICAM-1 staining of the vascular smooth muscle verified by staining for {alpha}-smooth muscle actin in Figure 3h.



View larger version (115K):
[in this window]
[in a new window]
 
Figure 3. Representative sections of vessels in subcutaneous fat immunostained for ICAM-1. a, Normal nonpregnant. b, Normal pregnant. c to f, Sequential sections of a PE patient (c, IgG-negative control; d, factor VIII; e, ICAM-1; f, {alpha}-smooth muscle actin). g and h, Sequential sections of a PE patient (g, ICAM-1; h, {alpha}-smooth muscle actin). Vessels of normal nonpregnant showed brown staining of ICAM-1 in the endothelium, but not vascular smooth muscle. Leukocytes also express ICAM-1; the bold arrow indicates one stained in the vessel lumen. Vessels of normal pregnant showed staining for ICAM-1 primarily in endothelial cells. Vessels of PE showed intense and diffuse brown staining for ICAM-1 of endothelium and vascular smooth muscle. Staining for {alpha}-smooth muscle actin in sequential sections confirmed ICAM-1 staining of vascular smooth muscle in PE. (VL indicates vessel lumen; VSM, vascular smooth muscle; EC, endothelial cell. All images are 400x magnification. Scale bars indicate 50 µm.

To verify specificity of the CD66b antigen for neutrophils, leukocytes were isolated from blood by histopaque density centrifugation. Neutrophils showed intense staining for CD66b, whereas monocytes and lymphocytes did not stain.

The percentage of vessels stained for CD66b was significantly greater for patients with preeclampsia than normal pregnant or normal nonpregnant patients (Figure 4a). There was also greater adherence and flattening of neutrophils along the endothelium (Figure 4b) and greater infiltration into the intima (Figure 4c). The total number of neutrophils adhered to endothelium and infiltrated into intima per stained vessel was greater for patients with preeclampsia (Figure 4d).



View larger version (17K):
[in this window]
[in a new window]
 
Figure 4. Staining of resistance-sized vessels for CD66b, a neutrophil marker. Normal nonpregnant and normal pregnant vessels had little neutrophil involvement as compared with PE vessels. In PE, there were significantly more vessels with staining for neutrophils (a), more vessels with neutrophils flattened and adhered to endothelial cells (b), more vessels with neutrophils infiltrated into intimal space (c), and higher number of neutrophils per vessel (8-µm-thick section) (d). Data are expressed as mean±SE. **P<0.01, ***P<0.001.

Representative sections of vessels for CD66b staining of neutrophils are shown in Figure 5. There was no staining for IgM-negative controls (data not shown). Few vessels for normal nonpregnant (Figure 5a) and normal pregnant patients (Figure 5b) had staining for CD66b except for occasional staining of neutrophils in the lumen or lightly attached to the endothelium. Stained neutrophils in normal nonpregnant and normal pregnant patients were generally rounded and it was rare to find neutrophils flattened to endothelium or infiltrated into the intima. In contrast, there was massive neutrophil involvement of vessels of women with preeclampsia with neutrophil adherence and flattening onto endothelium and infiltration into the intima. In some cases, vessels were almost occluded with neutrophils (Figure 5c through 5h).



View larger version (123K):
[in this window]
[in a new window]
 
Figure 5. Representative sections of vessels in subcutaneous fat immunostained for CD66b, a neutrophil marker. a, Normal nonpregnant. b, Normal pregnant. c to h, PE. Vessels of normal nonpregnant and normal pregnant had little or no staining for CD66b, although occasionally there were some stained neutrophils within the vessel lumen and along the endothelium (bold arrow in b). Vessels of PE showed extensive brown staining of neutrophils in the lumen, adhered and flattened along the endothelium (arrows in f), infiltrated into the intimal space, and present on the outside of the vessel (arrows in h). Diffuse staining was also evident, which probably represented CD66b secreted by neutrophils or neutrophils undergoing apoptosis. A indicates adipocyte; VL, vessel lumen; VW, vessel wall. All images are 400x, except (h), which is 1000x magnification. Scale bars indicate 50 µm.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
Staining for IL-8, a potent neutrophil chemotactic agent, was significantly greater in women with preeclampsia than normal pregnant or normal nonpregnant women. IL-8 staining was observed on vascular smooth muscle, in addition to endothelium, in women with preeclampsia. This finding is significant because it demonstrates inflammation of vascular smooth muscle in preeclampsia, and increased expression of vascular smooth muscle IL-8 establishes a concentration gradient for IL-8 from the circulation to the vascular smooth muscle. This provides a mechanism for transendothelial migration of neutrophils to the vascular smooth muscle because neutrophils migrate along a concentration gradient to IL-8.17

ICAM-1 was expressed on the endothelium in all groups. Endothelial ICAM-1 expression appeared to be downregulated in normal pregnancy. The most notable observation for ICAM-1 was that in patients with preeclampsia, ICAM-1 was expressed intensely on vascular smooth muscle. This corroborates the IL-8 data that there is inflammation of vascular smooth muscle in preeclampsia, because ICAM-1 is expressed by a variety of tissues under conditions of inflammation.18 Other investigators have reported markers of systemic inflammation in women with preeclampsia.19–22

The percentage of vessels stained for CD66b was significantly greater in women with preeclampsia than in normal pregnant or normal nonpregnant women. There were significantly more vessels with neutrophils adhered and flattened along the endothelium and within the intima in women with preeclampsia as compared with controls. The percentage of vessels with neutrophils present within different portions of the vessel correlated with an overall greater number of neutrophils per vessel. Diffuse vessel staining also was present in women with preeclampsia and, most likely, reflected secretion of CD66b from activated neutrophils or neutrophils undergoing apoptosis.

These new data may explain previous findings in preeclampsia. A study by Roggensack et al showed increased expression of nitrotyrosine, suggestive of peroxynitrite formation, a strong prooxidant, in the vasculature of women with preeclampsia.23 A simultaneous increase in the expression of endothelial nitric oxide synthase and a decrease in the expression of superoxide dismutase also were observed. Our findings may explain the source of superoxide for the formation of peroxynitrite, because the rapid interaction of neutrophil superoxide with endothelial nitric oxide in the presence of deficient superoxide dismutase would produce peroxynitrite. This would result in an endothelial deficiency of nitric oxide, which could result in increased vasomotor tone and hypertension. Our data, in conjunction with Roggensack’s data, strongly suggest that there is localized systemic oxidative stress throughout the maternal vasculature, which would result in lipid peroxidation leading to vascular inflammation and dysfunction.

Perspectives
The present study is the first to our knowledge to show that there is vascular smooth muscle inflammation and neutrophil infiltration into maternal systemic vascular tissue in preeclampsia. Neutrophil infiltration could explain clinical symptoms of hypertension, proteinuria, and edema.


*    Acknowledgments
 
This study was funded by grants from the American Heart Association (AHA0051292U) and the National Institutes of Health (NIH HL069851) to S.W.W.


*    Footnotes
 
Presented at the Annual Meeting of the Society for Gynecologic Investigation, Washington, DC, March 26–30, 2003 and published in abstract form (J Soc Gynecol Invest. 2003;10:504A).

Received February 2, 2004; first decision February 18, 2004; accepted April 21, 2004.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Edwards SW. Biochemistry and Physiology of the Neutrophil. New York, NY: Cambridge University Press; 1994.

2. Luster AD. Chemokines–chemotactic cytokines that mediate inflammation. N Engl J Med. 1998; 338: 436–445.[Free Full Text]

3. Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC, III, Hauth JC, Wenstrom KD. Williams Obstetrics. 21st ed. New York: McGraw-Hill; 2001.

4. Clark P, Boswell F, Greer IA. The neutrophil and preeclampsia. Semin Reprod Endocrinol. 1998; 16: 57–64.[Medline] [Order article via Infotrieve]

5. Walsh SW. Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia. Semin Reprod Endocrinol. 1998; 16: 93–104.[Medline] [Order article via Infotrieve]

6. Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med. 1999; 222: 222–235.[Abstract/Free Full Text]

7. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989; 161: 1200–1204.[Medline] [Order article via Infotrieve]

8. Greer IA, Haddad NG, Dawes J, Johnstone FD, Calder AA. Neutrophil activation in pregnancy-induced hypertension. Br J Obstet Gynaecol. 1989; 96: 978–982.[Medline] [Order article via Infotrieve]

9. Tsukimori K, Maeda H, Ishida K, Nagata H, Koyanagi T, Nakano H. The superoxide generation of neutrophils in normal and preeclamptic pregnancies. Obstet Gynecol. 1993; 81: 536–540.[Medline] [Order article via Infotrieve]

10. Sacks GP, Studena K, Sargent IL, Redman CWG. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol. 1998; 179: 80–86.[CrossRef][Medline] [Order article via Infotrieve]

11. Gervasi MT, Chaiworapongsa T, Pacora P, Naccasha N, Yoon BH, Maymon E, Romero R. Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia. Am J Obstet Gynecol. 2001; 185: 792–797.[CrossRef][Medline] [Order article via Infotrieve]

12. Barden A, Graham D, Beilin LJ, Ritchie J, Baker R, Walters BN, Michael CA. Neutrophil CD11B expression and neutrophil activation in pre-eclampsia. Clin Sci. 1997; 92: 37–44.[Medline] [Order article via Infotrieve]

13. Walsh SW. Lipid peroxidation in pregnancy. Hypertens Pregnancy. 1994; 13: 1–32.[CrossRef]

14. Mellembakken JR, Aukrust P, Olafsen MK, Ueland T, Hestdal K, Videm V. Activation of leukocytes during the uteroplacental passage in preeclampsia. Hypertension. 2002; 39: 155–160.[Abstract/Free Full Text]

15. Lurie S, Frenkel E, Tuvbin Y. Comparison of the differential distribution of leukocytes in preeclampsia versus uncomplicated pregnancy. Gynecol Obstet Invest. 1998; 45: 229–231.[CrossRef][Medline] [Order article via Infotrieve]

16. Conti P, Cifone MG, Alesse E, Reale M, Fieschi C, Dinarello CA. In vitro enhanced thromboxane B2 release by polymorphonuclear leukocytes and macrophages after treatment with human recombinant interleukin 1. Prostaglandins. 1986; 32: 111–115.[Medline] [Order article via Infotrieve]

17. Smart SJ, Casale TB. Interleukin-8-induced transcellular neutrophil migration is facilitated by endothelial and pulmonary epithelial cells. Am J Respir Cell Mol Biol. 1993; 9: 489–495.[Medline] [Order article via Infotrieve]

18. Roebuck KA, Finnegan A. Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J Leukoc Biol. 1999; 66: 876–888.[Abstract]

19. Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol. 1998; 40: 102–111.[Medline] [Order article via Infotrieve]

20. Granger JP, Alexander BT, Bennett WA, Khalil RA. Pathophysiology of pregnancy-induced hypertension. Am J Hypertens. 2001; 14: 178S–185S.[CrossRef][Medline] [Order article via Infotrieve]

21. Qiu C, Luthy DA, Zhang C, Walsh SW, Leisenring WM, Williams MA. A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia. Am J Hypertens. 2004; 17: 154–160.[CrossRef][Medline] [Order article via Infotrieve]

22. Williams MA, Farrand A, Mittendorf R, Sorensen TK, Zingheim RW, O’Reilly GC, King IB, Zebelman AM, Luthy DA. Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia. Am J Epidemiol. 1999; 149: 323–329.[Abstract/Free Full Text]

23. Roggensack AM, Zhang Y, Davidge ST. Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension. 1999; 33: 83–89.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
HypertensionHome page
S. Verlohren, D. N. Muller, F. C. Luft, and R. Dechend
Immunology in Hypertension, Preeclampsia, and Target-Organ Damage
Hypertension, September 1, 2009; 54(3): 439 - 443.
[Full Text] [PDF]


Home page
Reproductive SciencesHome page
S. W. Walsh
Plasma From Preeclamptic Women Stimulates Transendothelial Migration of Neutrophils
Reproductive Sciences, March 1, 2009; 16(3): 320 - 325.
[Abstract] [PDF]


Home page
J. Immunol.Home page
Y. Gu, D. F. Lewis, K. Deere, L. J. Groome, and Y. Wang
Elevated Maternal IL-16 Levels, Enhanced IL-16 Expressions in Endothelium and Leukocytes, and Increased IL-16 Production by Placental Trophoblasts in Women with Preeclampsia
J. Immunol., September 15, 2008; 181(6): 4418 - 4422.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. D. LaMarca, J. Gilbert, and J. P. Granger
Recent Progress Toward the Understanding of the Pathophysiology of Hypertension During Preeclampsia
Hypertension, April 1, 2008; 51(4): 982 - 988.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Tesse, F. Meziani, E. David, N. Carusio, H. Kremer, F. Schneider, and R. Andriantsitohaina
Microparticles from preeclamptic women induce vascular hyporeactivity in vessels from pregnant mice through an overproduction of NO
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H520 - H525.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. W. Walsh
What Causes Endothelial Cell Activation in Preeclamptic Women?
Am. J. Pathol., October 1, 2006; 169(4): 1104 - 1106.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Meziani, A. Tesse, E. David, M. C. Martinez, R. Wangesteen, F. Schneider, and R. Andriantsitohaina
Shed Membrane Particles from Preeclamptic Women Generate Vascular Wall Inflammation and Blunt Vascular Contractility
Am. J. Pathol., October 1, 2006; 169(4): 1473 - 1483.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
C. E. Leik and S. W. Walsh
Systemic Activation and Vascular Infiltration of Neutrophils With Term Labor
Reproductive Sciences, September 1, 2006; 13(6): 425 - 429.
[Abstract] [PDF]


Home page
Circ. Res.Home page
O. Krysiak, A. Bretschneider, E. Zhong, J. Webb, H. Hopp, S. Verlohren, N. Fuhr, M. Lanowska, A. Nonnenmacher, R. Vetter, et al.
Soluble Vascular Endothelial Growth Factor Receptor-1 (sFLT-1) Mediates Downregulation of FLT-1 and Prevents Activated Neutrophils From Women With Preeclampsia From Additional Migration by VEGF
Circ. Res., December 9, 2005; 97(12): 1253 - 1261.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
C. E. Leik and S. W. Walsh
Linoleic Acid, but not Oleic Acid, Upregulates Production of Interleukin-8 by Human Vascular Smooth Muscle Cells via Arachidonic Acid Metabolites Under Conditions of Oxidative Stress
Reproductive Sciences, December 1, 2005; 12(8): 593 - 598.
[Abstract] [PDF]


Home page
Reproductive SciencesHome page
R. B. Donker, G. Molema, M. M. Faas, C. G.M. Kallenberg, M. G. van Pampus, A. Timmer, and J. G. Aarnoudse
Absence of In Vivo Generalized Pro-Inflammatory Endothelial Activation in Severe, Early-Onset Preeclampsia
Reproductive Sciences, October 1, 2005; 12(7): 518 - 528.
[Abstract] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
44/1/72    most recent
01.HYP.0000130483.83154.37v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leik, C. E.
Right arrow Articles by Walsh, S. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leik, C. E.
Right arrow Articles by Walsh, S. W.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*High Risk Pregnancy
Related Collections
Right arrow Other hypertension
Right arrow Other Vascular biology